<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Vitamin A: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Vitamin A: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Vitamin A: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12152" href="/d/html/12152.html" rel="external">see "Vitamin A: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12883" href="/d/html/12883.html" rel="external">see "Vitamin A: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F234440"><span class="drugH1">Brand Names: US</span>
<ul>
<li>A-25 [OTC];</li>
<li>Aquasol A;</li>
<li>Gordons-Vite A [OTC];</li>
<li>True Vitamin A [OTC];</li>
<li>Vitamin A Fish [OTC]</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F234456"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Vitamin, Fat Soluble</li></ul></div>
<div class="block doa drugH1Div" id="F234443"><span class="drugH1">Dosing: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Oral OTC supplements containing vitamin A may express the amount as mcg (retinol activity equivalents [RAE]) instead of (or in addition to) units; <b>1 unit = 0.3 mcg (RAE) = 0.3 mcg retinol</b> (ASPEN [Vanek 2012]; IOM 2001).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="81863c66-ac4f-45ff-b638-ded564c6efe2">Dietary supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary supplement: Oral: </b>One tablet or capsule daily; dosage may vary depending on dosage form; consult specific product labeling.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d7233376-6ee4-4b85-b78b-c5333a57e26b">Vitamin A deficiency, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin A deficiency, treatment: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Manufacturer recommendation: IM: Note:</b> IM route is indicated when oral administration is not feasible or when absorption is insufficient (malabsorption syndrome): 100,000 units (30,000 mcg)/day for 3 days, followed by 50,000 units (15,000 mcg)/day for 2 weeks.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Follow-up therapy with an oral therapeutic multivitamin (containing additional vitamin A) is recommended: <b>Oral:</b> 10,000 to 20,000 <b>units</b> (3,000 to 6,000 <b>mcg</b>)/day for 2 months.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8ade6f38-498a-4aaa-a4f4-64508fc7230b">Vitamin A deficiency, prophylaxis in patients at high risk for deficiency</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin A deficiency, prophylaxis in patients at high risk for deficiency (off-label dose)</b> (eg, persons living in developing areas of the world where deficiency is a public health problem, especially persons with severe infectious disease or malnutrition): <b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Adults: 200,000 <b>units</b> (60,000 <b>mcg</b>)/dose every 6 months (WHO 2008)</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnant females: Maximum 10,000 <b>units</b> (3,000 <b>mcg</b>)/day or 25,000 <b>units</b> (7,500 <b>mcg</b>) once weekly. Administer for a minimum of 12 weeks during pregnancy or until delivery (WHO 2008; WHO 2011c)</p>
<p style="text-indent:-2em;margin-left:4em;">Postpartum females: 200,000 <b>units</b> (60,000 <b>mcg</b>) at delivery or within 8 weeks of delivery (WHO 2008)</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2faac157-cb72-4483-bd00-4d28ece72052">Xerophthalmia, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Xerophthalmia, treatment (off-label use):</b>
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Adults (except females of reproductive age): 200,000 <b>units</b> (60,000 <b>mcg</b>) once daily for 2 days; repeat with single dose after 2 weeks (WHO 2008).</p>
<p style="text-indent:-2em;margin-left:4em;">Females of reproductive age (WHO 1997; WHO 2008):</p>
<p style="text-indent:-2em;margin-left:6em;">With night blindness or Bitot's spots (less severe xerophthalmia): 5,000 to 10,000 <b>units</b> (1,500 to 3,000 <b>mcg</b>)/day (maximum 10,000 <b>units</b> [3,000 <b>mcg</b>]/day) or ≤25,000 <b>units</b> (≤7,500 <b>mcg</b>) once weekly for ≥4 weeks.</p>
<p style="text-indent:-2em;margin-left:6em;">Severe xerophthalmia: Refer to adult dosing.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990583"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987942"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F234444"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F234451"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12883" href="/d/html/12883.html" rel="external">see "Vitamin A: Pediatric drug information"</a>)</p>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Vitamin A products may express the amount as mcg (retinol activity equivalents [RAE]) instead of (or in addition to) units; <b>1 unit retinol = 0.3 mcg RAE = 0.3 mcg retinol</b> (NIH 2019).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="fd7cb78c-4b3c-4514-9f55-4b7e304593bd">Cystic fibrosis supplementation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cystic fibrosis supplementation:</b>
<b>Note:</b> Typically administered as part of a fixed dosage product with other fat-soluble vitamins (eg, ADEK); however, some patients may require higher doses based on condition (CF liver disease [Debray 2011]); doses presented are in addition to usual RDA for age.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Oral: 1,500 units/day (450 mcg RAE/day) (Borowitz 2002; Borowitz 2009).</p>
<p style="text-indent:-2em;margin-left:4em;">Children 1 to 3 years: Oral: 5,000 units/day (1,500 mcg RAE/day) (Borowitz 2002; Lahiri 2016).</p>
<p style="text-indent:-2em;margin-left:4em;">Children 4 to 8 years: Oral: 5,000 to 10,000 units/day (1,500 to 3,000 mcg RAE/day) (Borowitz 2002; Lahiri 2016).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥9 years and Adolescents: Oral: 10,000 units/day (3,000 mcg RAE/day) (Borowitz 2002); some data suggest that dose should be individualized based on patient serum concentrations. Based on current US recommendations, some available multivitamin products may be excessive based on patient's needs, particularly in preadolescent patients (Bonifant 2014; Brei 2013; Graham-Maar 2006).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ef582d50-dd44-426d-b9ab-6875024567d6">Malabsorption; supplementation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Malabsorption (eg, cholestasis, biliary atresia); supplementation:</b> Limited data available: Children and Adolescents: <b>Note:</b> Specific dose should be based on serum markers and clinical condition; dose should be individualized: Oral: 5,000 to 15,000 units/day (1,500 to 4,500 mcg RAE/day) of water miscible product (eg, Aquasol A); begin at low end of the range for younger patients (Kelly 2007; Kliegman 2020).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="09095639-0af1-4022-bc95-67bd47fcd293">Measles infection, supplementation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Measles infection, supplementation:</b> Limited data available (WHO 2004; WHO 2010; WHO 2017): Therapy should be initiated immediately upon diagnoses irrespective of previous doses (WHO 2017).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants &lt;6 months: Oral: 50,000 units/day (15,000 mcg RAE/day) for 2 days.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants 6 to 11 months: Oral: 100,000 units/day (30,000 mcg RAE/day) for 2 days.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥12 months and Children: Oral: 200,000 units/day (60,000 mcg RAE/day) for 2 days.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note</b>: If severe malnutrition or ophthalmologic evidence of vitamin A deficiency is present, administer a third dose 4 to 6 weeks after the second dose (WHO 2017); earlier administration of the third dose at 2 to 4 weeks following the second dose has also been suggested (AAP [Redbook 2018]; WHO 2004; WHO 2010).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1e5d0006-069c-45f1-8639-d5dadeffe5de">Vitamin A deficiency; prevention for geographical at-risk populations</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin A deficiency; prevention for geographical at-risk populations: Note:</b> Supplementation recommended in areas where vitamin A deficiency is a public health problem, including local prevalence of night blindness ≥1% in ages 24 to 59 months or prevalence of serum retinol ≤0.7 mmol/L is ≥20% in ages 6 to 59 months (WHO 2011).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥6 months: Oral: 100,000 units/dose (30,000 mcg RAE/dose) administered once.</p>
<p style="text-indent:-2em;margin-left:4em;">Children &lt;5 years: Oral: 200,000 units/dose (60,000 mcg RAE/dose) administered as a single dose every 4 to 6 months.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d7233376-6ee4-4b85-b78b-c5333a57e26b">Vitamin A deficiency, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Vitamin A deficiency, treatment: </b></p>
<p style="text-indent:-2em;margin-left:4em;">Initial:</p>
<p style="text-indent:-2em;margin-left:6em;">Infants: IM: 7,500 to 15,000 units/dose (2,250 to 4,500 mcg RAE/dose) once daily for 10 days followed by oral supplementation.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 1 to 8 years: IM: 17,500 to 35,000 units/dose (5,250 to 10,500 mcg RAE/dose) once daily for 10 days followed by oral supplementation.</p>
<p style="text-indent:-2em;margin-left:6em;">Children &gt;8 years and Adolescents: IM: 100,000 units/dose (30,000 mcg RAE/dose) once daily for 3 days; then 50,000 units/dose (15,000 mcg RAE/dose) once daily for 14 days followed by oral supplementation.</p>
<p style="text-indent:-2em;margin-left:4em;">Maintenance oral supplementation: After completion of an IM course to correct deficiency, patient should continue on an oral supplementation for 2 months with a multivitamin preparation that contains: Infants and children &lt;8 years: 5,000 to 10,000 units/day (1,500 to 3,000 mcg RAE/day); children ≥8 years and adolescents: 10,000 to 20,000 units/day (3,000 to 6,000 mcg RAE/day).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="4c60585d-6e4d-4078-9d32-db0304f44a60">Xerophthalmia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Xerophthalmia: </b>Limited data available (WHO 1997; WHO 2010):</p>
<p style="text-indent:-2em;margin-left:4em;">Infants &lt;6 months: Oral: 50,000 units (15,000 mcg RAE) administered as a single dose; repeat the next day and again after at least 2 weeks for a total of 3 doses.</p>
<p style="text-indent:-2em;margin-left:4em;">Infants 6 to 12 months: Oral: 100,000 units (30,000 mcg RAE) administered as a single dose; repeat the next day and again after at least 2 weeks for a total of 3 doses.</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 200,000 units (60,000 mcg RAE) administered as a single dose; repeat the next day and again after at least 2 weeks for a total of 3 doses.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51193279"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51193280"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F234415"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Frequency not defined: Hypersensitivity: Anaphylactic shock (following IV administration), hypersensitivity reaction (rare), intracranial hypertension (Tan 2019)</p></div>
<div class="block coi drugH1Div" id="F234428"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to vitamin A or any component of the formulation; hypervitaminosis A; pregnancy (dose exceeding RDA); intravenous administration of Aquasol A</p></div>
<div class="block war drugH1Div" id="F234412"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Parenteral vitamin A: In low birth weight infants, polysorbates have been associated with thrombocytopenia, renal dysfunction, hepatomegaly, cholestasis, ascites, hypotension, and metabolic acidosis (E-Ferol syndrome).</p>
<p style="text-indent:-2em;margin-left:4em;">• Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson 2002; Lucente 2000; Shelley 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade 1986; CDC 1984). See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Evaluate other sources of vitamin A while receiving this product; patients receiving &gt;25,000 units/day should be closely monitored for toxicity.</p></div>
<div class="block foc drugH1Div" id="F234422"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Capsule, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">A-25: 7.5 MG (25000 UT)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">True Vitamin A: 8000 units</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Vitamin A Fish: 2250 MCG (7500 UT)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 3 MG (10000 UT)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Capsule, Oral [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2400 MCG (8000 UT)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gordons-Vite A: 100,000 units/g (75 g, 120 g, 480 g, 2400 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Gordons-Vite A: 100,000 units (120 mL, 3840 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intramuscular: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Aquasol A: 15 mg/mL (2 mL [DSC]); 50,000 units/mL (2 mL) [contains chlorobutanol (chlorobutol), polysorbate 80]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 3 MG (10000 UT), 4.5 MG (15000 UT)</p></div>
<div class="block geq drugH1Div" id="F234408"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F16324099"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Vitamin A Fish Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2250 MCG(7500 UT) (per each): $0.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Vitamin A Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">3 MG(10000 UT) (per each): $0.03 - $0.05</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2400 MCG(8000 UT) (per each): $0.04</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Gordons-Vite A External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">100000 units/g (per gram): $0.17</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Gordons-Vite A External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">100000 unit (per mL): $0.07</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Aquasol A Intramuscular)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">50000 units/mL (per mL): $431.25</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block adm drugH1Div" id="F234425"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>IM:</b> Administer as an intramuscular injection. <b>Note: IV administration is contraindicated.</b></p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral: </b>Administer with food.</p></div>
<div class="block admp drugH1Div" id="F52614012"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Administer with food or milk; for infants and children &lt;24 months of age, capsules may be cut open and contents squeezed into the mouth (WHO 2004).</p>
<p style="text-indent:-2em;margin-left:2em;">Parenteral: <b>For IM use only</b>; for neonatal patients, a 0.3 mL syringe and 29-gauge needle should be used for IM dose administration (Tyson 1999).</p></div>
<div class="block use drugH1Div" id="F234424"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">Treatment of vitamin A deficiency; parenteral (IM) route is indicated when oral administration is not feasible or when absorption is insufficient (malabsorption syndrome); dietary supplement when vitamin A intake may be inadequate (OTC).</p></div>
<div class="block off-label drugH1Div" id="F25744936"><span class="drugH1">Use: Off-Label: Adult</span><p>Xerophthalmia caused by vitamin A deficiency</p></div>
<div class="block mst drugH1Div" id="F234464"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Aquasol may be confused with Anusol</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">High alert medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs that have a heightened risk of causing significant patient harm when used in error.</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13300220"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F234417"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Bexarotene (Topical): Vitamin A may enhance the adverse/toxic effect of Bexarotene (Topical).  Management: Limit doses of vitamin A to 5,000 units per day if combined with topical bexarotene.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Orlistat: May decrease the absorption of Vitamins (Fat Soluble). Management: Administer oral fat soluble vitamins at least 2 hours before or 2 hours after the administration of orlistat. Avoid concomitant administration due to the risk of impaired vitamin absorption.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Retinoic Acid Derivatives: Vitamin A may enhance the adverse/toxic effect of Retinoic Acid Derivatives. <i> Risk X: Avoid combination</i></p></div>
<div class="block foi drugH1Div" id="F14315239"><span class="drugH1">Food Interactions</span>
<p style="text-indent:0em;display:inline">Excessive ethanol intake depletes the liver of vitamin A and may enhance vitamin A toxicity (IOM 2000)</p></div>
<div class="block rep_considerations drugH1Div" id="F53632826"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:0em;">Doses greater than the RDA are contraindicated in women who may become pregnant. High doses are used in some areas of the world for supplementation where deficiency is a public health problem (eg, to prevent night blindness); however, single doses &gt;25,000 units should be avoided within 60 days of conception. High-dose supplementation is otherwise not recommended as part of routine antenatal care (WHO 2011c).</p></div>
<div class="block pri drugH1Div" id="F234431"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Excess vitamin A during pregnancy may cause craniofacial malformations, as well as CNS, heart, and thymus abnormalities. Maternal vitamin A deficiency also causes adverse effects in the fetus, and vitamin A requirements are increased in pregnant women (IOM 2000). The manufacturer notes that the safety of doses &gt;6,000 units/day in pregnant women has not been established and doses greater than the RDA are contraindicated in pregnant women.</p></div>
<div class="block brc drugH1Div" id="F14315219"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Vitamin A requirements are increased in breastfeeding women (IOM 2000). High-dose supplementation (eg, doses higher than the RDA) is not recommended in otherwise healthy women who receive adequate nutrition (WHO 2011b).</p></div>
<div class="block dic drugH1Div" id="F14315240"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Dairy products, fish, and liver are common dietary sources of vitamin A; broccoli, cantaloupe, carrots, peas, spinach, and squash are sources of beta-carotene (which is converted to vitamin A) (IOM 2000)</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary reference Intake </b>(presented as retinol activity equivalent [RAE]) (IOM 2001):</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: Adequate intake: 400 mcg/day (1,330 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: Adequate intake: 500 mcg/day (1,670 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: RDA: 300 mcg/day (1,000 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: RDA: 400 mcg/day (1,330 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years: RDA: 600 mcg/day (2,000 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">&gt;13 years: RDA: Females: 700 mcg/day (2,330 units/day); Males: 900 mcg/day (3,000 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnancy: RDA: 14 to 18 years: 750 mcg/day (2,500 units/day); ≥19 years: 770 mcg/day (2,560 units/day)</p>
<p style="text-indent:-2em;margin-left:4em;">Lactation: RDA: 14 to 18 years: 1,200 mcg/day (4,000 units/day); ≥19 years: 1,300 mcg/day (4,330 units/day)</p></div>
<div class="block mop drugH1Div" id="F50847061"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Serum retinol</p></div>
<div class="block pha drugH1Div" id="F234411"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Vitamin A is a fat soluble vitamin needed for visual adaptation to darkness, maintenance of epithelial cells, immune function and embryonic development.</p></div>
<div class="block phk drugH1Div" id="F234427"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Vitamin A in dosages <b>not</b> exceeding physiologic replacement is well absorbed in the small intestine after oral administration; water miscible preparations are absorbed more rapidly than oil preparations; large oral doses, conditions of fat malabsorption, low protein intake, or hepatic or pancreatic disease reduces oral absorption </p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Distribution: Large amounts concentrate for storage in the liver</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Metabolism: Converted in the small intestine to retinol and further metabolized in the liver; conjugated with glucuronide; undergoes enterohepatic recirculation</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Excretion: Feces; urine</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F5539954"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Acon | Arovit | Vitamin A</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">A-vitel | Amenite A | Bagovit a | Cazmar | Dermis albula | Domsedan | Fiosen a | Midermus a | Roavit | Skinderm a | Tanvimil a | Vitamina A | Vitamina a</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Avitol | Oleovit</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Lifil a | Ovit a | Ratinol</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Acaren | Arovit</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Vitamine a</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A | Vitamin a</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">A 8000 | Arovit | Farmanguinhos vitamina a | Fonto-vit a | Proway vitamina a | Retinar | Retinol Vitamina a | Sidney oliveira vitamina a | Vitamin A | Vitamina a | Vitamina A | Vitamina a retinol</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Burgerstein vitamin a | Vitamin A Streuli</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Avitana | Bagovit-a | Microret | Retinol | Ystheal</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Aua vitamina a palmitato | Complete juice | Retiblan | Tersaderm | Vitamina a | Vitamina A</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Axerophtol | Vitamin A | Vitamin a forte | Vitaminum and hasco</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Aportha vitamin a | Augenkraft vit a | Pure encapsulations vitamin a | Reti nit | Retinol | Sanhelios augen vit a | Sovita Vitamin A | Vitamin A | Vitamin a | Vitamin A Saar</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Acon | Avit | Bagovit a | Retiblan | Vitamina A</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Retinol | Vitamina A</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Lamberts vitamin a | Now vitamin a | Vitamiin A | Vitamin A | Vitamin a</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">A viton | Abi vit a | Abivit a | Vitamin A | Vitamin a</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Auxina a masiva | Dif vitamin a</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">A-vita | A-vitamiini | Asol | Bellavita</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">A 313 | Arovit | Avibon</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A Palmitate</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Novaquasol a | Vitamine a</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Avitin | Vitamin A | Vitamin a</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Avipur | Vitamin A</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Aquasol a | Arovit | Mix carotin | Prepalin | Vitamin A | Yugard</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Akeral | Arovit | Euvitol | Repervit | Vitamina a</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Univit A | Vitamin A</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Retinol | Vitamin A</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Helenux | Vitamin A</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">A viton | Vitamin A</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Vitamin A</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Retinoli acetas | Vitamin A | Vitamin a | Vitaminas A</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Abc vit vitamin a | Moellers dobbel | Retinol acetas | Retinol acetat | Vitamin A | Vitamin a</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Arovit</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Acon | Avinal ex | Biolysin gb | Dermotin-a | Microret | Vitamina a gri</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Clarion vitamin a | Everdestiny vitamin a | Jesdol</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Dagravit a forte</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Burgerstein vitamin a | Nature's own vitamin a | Ro-a-vit | Thompson's vitamin a | Vitamin A</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Bio crem a | Epiteliol | Mirtoran-a | Retavit | Vitamina A</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Afaxin | Alici A | Re view</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Avita | Vitamin A</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Vitamin A | Vitaminum a</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Aquasol a | Betavit | Palmitate-a | Vitamin A Palmitate</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">A vite</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Bidotan | Masivol | Tanvimil a | Vitasan a</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">A-Viton</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Vitamin a</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Aevit | Retinol | Retinol Palmitat | Vitamin a | Vitamin A</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">A viton | Arovit</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Ido-a</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Axerophtol | Vitamin A</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">21st century a | A-vit | Arovit | Bio-a | P | Vitamin a | Vitamin A | Vitamin a atlantic</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Avibon | Vitamine a</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Avicap | Avigen | Zade vital a vitamini</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Aetomin | Arcavit A | Avitol | Bezin | Fulimin | Ginzone | Vitamin A</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Retinol acetat | Retinol Palmitat | Vitamin A</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Avit</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Arovit | Bagovit a | Demivis | Eternovit A | Masivol | Vitamina A</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Alfa-mon | Retiva | Vitamina a | Vitamina A</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Agirenyl</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Aquanel | Arovit | Vitaforce vitamin a | Vitamin a | Vitamin-a</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3960626">
<a name="3960626"></a>Alade SL, Brown RE, Paquet A Jr. Polysorbate 80 and E-Ferol toxicity.<i> Pediatrics</i>. 1986;77(4):593-597.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/3960626/pubmed" id="3960626" target="_blank">3960626</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15713907">
<a name="15713907"></a>Ambalavanan N, Tyson JE, Kennedy KA, et al; National Institute of Child Health and Human Development Neonatal Research Network. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. <i>Pediatrics</i>. 2005;115(3):e249-e254. doi:10.1542/peds.2004-1812<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/15713907/pubmed" id="15713907" target="_blank">15713907</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2018 Report of the Committee on Infectious Diseases</i>. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.1">
<a name="AAP.1"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Brady MT, Jackson MA, Long SA, eds. <i>Red Book: 2021 Report of the Committee on Infectious Diseases</i>. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Aquasol.1">
<a name="Aquasol.1"></a>Aquasol A Parenteral (water-miscible vitamin A palmitate) [prescribing information]. East Brunswick, NJ: Casper Pharma; October 2019.</div>
</li>
<li>
<div class="reference">
                  Benjamin JT, Jensen EA. Bronchopulmonary dysplasia. In: Eichenwald EC, Hansen AR, Martin CR, Stark AR, eds. <i>Manual of Neonatal Care</i>. 9th ed. Lippincott Williams &amp; Wilkins; 2022:chap 34.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24823814">
<a name="24823814"></a>Bonifant CM, Shevill E, Chang AB. Vitamin A supplementation for cystic fibrosis. <i>Cochrane Database Syst Rev</i>. 2014;(5):CD006751.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/24823814/pubmed" id="24823814" target="_blank">24823814</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12352509">
<a name="12352509"></a>Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. <i>J Pediatr Gastroenterol Nutr</i>. 2002;35(3):246-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/12352509/pubmed" id="12352509" target="_blank">12352509</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19914445">
<a name="19914445"></a>Borowitz D, Robinson KA, Rosenfeld M, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. <i>J Pediatr</i>. 2009;155(6 Suppl):S73-93.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/19914445/pubmed" id="19914445" target="_blank">19914445</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23395254">
<a name="23395254"></a>Brei C, Simon A, Krawinkel MB, Naehrlich L. Individualized vitamin A supplementation for patients with cystic fibrosis. <i>Clin Nutr</i>. 2013;32(5):805-810.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/23395254/pubmed" id="23395254" target="_blank">23395254</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control and Prevention (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6423951">
<a name="6423951"></a>Centers for Disease Control and Prevention (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product.<i> MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199.<a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/6423951/pubmed" id="6423951" target="_blank">6423951</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27552058">
<a name="27552058"></a>Darlow BA, Graham PJ, Rojas-Reyes MX. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants (review). <i>Cochrane Database Syst Rev</i>. 2016;2016(8):CD000501. doi:10.1002/14651858.CD000501.pub4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/27552058/pubmed" id="27552058" target="_blank">27552058</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21658639">
<a name="21658639"></a>Debray D, Kelly D, Houwen R, Strandvik B, Colombo C. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. <i>J Cyst Fibros</i>. 2011;10 Suppl 2:S29-36.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/21658639/pubmed" id="21658639" target="_blank">21658639</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16825693">
<a name="16825693"></a>Graham-Maar RC, Schall JI, Stettler N, Zemel BS, Stallings VA. Elevated vitamin A intake and serum retinol in preadolescent children with cystic fibrosis. <i>Am J Clin Nutr</i>. 2006;84(1):174-182.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/16825693/pubmed" id="16825693" target="_blank">16825693</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  IOM (Institute of Medicine), <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>, Washington, DC: National Academy Press, 2000.</div>
</li>
<li>
<div class="reference">
                  IOM (Institute of Medicine) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academy Press, 2001.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12534540">
<a name="12534540"></a>Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatitis</i>. 2002;47(5):312-313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/12534540/pubmed" id="12534540" target="_blank">12534540</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17878208">
<a name="17878208"></a>Kelly DA, Davenport M. Current management of biliary atresia. <i>Arch Dis Child</i>. 2007;92(12):1132-1135.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/17878208/pubmed" id="17878208" target="_blank">17878208</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Kliegman RM and St. Geme J, eds. <i>Nelson Textbook of Pediatrics</i>. 21st ed. Philadelphia, PA: Saunders Elsevier; 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27009033">
<a name="27009033"></a>Lahiri T, Hempstead SE, Brady C, et al. Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis. <i>Pediatrics</i>. 2016;137(4). pii: e20151784.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/27009033/pubmed" id="27009033" target="_blank">27009033</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10985636">
<a name="10985636"></a>Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/10985636/pubmed" id="10985636" target="_blank">10985636</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  National Institutes of Health (NIH) Office of Dietary Supplements. Vitamin A Fact Sheet for Health Professionals. Available at: <a href="https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional" target="_blank">https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional</a>. Updated July 9, 2019. Accessed July 29, 2019.</div>
</li>
<li>
<div class="reference">
                  National Institutes of Health (NIH) Office of Dietary Supplements. Vitamin A Fact Sheet for Health Professionals. Available at: <a href="https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional" target="_blank">https://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional</a>. Updated June 15, 2022. Accessed August 9, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12221268">
<a name="12221268"></a>Ross DA. Recommendations for vitamin A supplementation. <i>J Nutr</i>. 2002;132(9 suppl):S2902-S2906. doi:10.1093/jn/132.9.2902S<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/12221268/pubmed" id="12221268" target="_blank">12221268</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7746084">
<a name="7746084"></a>Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity.<i> Lancet</i>. 1995;345(8960):1312-1313.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/7746084/pubmed" id="7746084" target="_blank">7746084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Stinchfield.1">
<a name="Stinchfield.1"></a>Stinchfield PA, Orenstein WA. Vitamin A for the management of measles in the United States. <i>Infect Dis Clin Pract</i> 2020;28:181-187.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31741184">
<a name="31741184"></a>Tan MG, Worley B, Kim WB, Ten Hove M, Beecker J. Drug-induced intracranial hypertension: a systematic review and critical assessment of drug-induced causes [published online November 18, 2019]. <i>Am J Clin Dermatol</i>.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/31741184/pubmed" id="31741184" target="_blank">31741184</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Tyson JE, Wright LL, Oh W, et al, "Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants. National Institute of Child Health and Human Development Neonatal Research Network," <i>N Engl J Med</i>, 1999, 340(25):1962-8.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract.</i> 2012;27(4):440-491. doi: 10.1177/0884533612446706. Erratum in: <i>Nutr Clin Pract.</i> 2014;29(5):701.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Mason.1">
<a name="Mason.1"></a>Vitamin A softgels [prescribing information]. Miami Lakes, FL: Mason Vitamins; September 2019.</div>
</li>
<li>
<div class="reference">
                  WHO Guideline, "Vitamin A Supplementation in Infants 1–5 Months of Age," Geneva: World Health Organization, 2011a. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_infants_1-5/en/
                  </div>
</li>
<li>
<div class="reference">
                  WHO Guideline, "Vitamin A Supplementation in Postpartum Women," Geneva: World Health Organization, 2011b. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_postpartum/en/
                  </div>
</li>
<li>
<div class="reference">
                  WHO Guideline, "Vitamin A Supplementation in Pregnant Women," Geneva: World Health Organization, 2011c. Available at http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_pregnant/en/
                  </div>
</li>
<li>
<div class="reference">
<i>WHO Model Formulary</i>, 2008. Available at http://apps.who.int/medicinedocs/documents/s16879e/s16879e.pdf
                  </div>
</li>
<li>
<div class="reference">
<i>WHO Model Formulary for Children</i>, 2010. Available at https://www.who.int/publications/i/item/9789241599320
                  </div>
</li>
<li>
<div class="reference">
                  WHO/UNICEF/IVACG Task Force, <i>Vitamin A Supplements. A Guide to Their Use in the Treatment and Prevention of Vitamin A Deficiency and Xerophthalmia</i>, 2nd ed. Geneva: World Health Organization, 1997. Available at http://www.who.int/nutrition/publications/micronutrients/vitamin_a_deficiency/9241545062/en/
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28459148">
<a name="28459148"></a>World Health Organization (WHO). Measles vaccines: WHO position paper – April 2017. <i>Wkly Epidemiol Rec</i>. 2017;92(17):205-227.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/vitamin-a-drug-information/abstract-text/28459148/pubmed" id="28459148" target="_blank">28459148</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  World Health Organization (WHO). Treating Measles in Children. 2004. Available at https://iris.who.int/handle/10665/63706
                  </div>
</li></ol></div><div id="topicVersionRevision">Topic 10047 Version 214.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
